Training | 2021.03.12
Following Federal DEA & FDA directives-MMJ International Holdings Completing THC & CBD Marijuana Gel Capsule Manufacturing for Clinical Trials in MS and HD
"DEA anticipates that additional strains of marihuana will be produced and made available to researchers. This should facilitate research, advance scientific understanding about the effects of marihuana, and potentially aid in the development of safe and effective drug products that may be approved for marketing by the Food and Drug Administration."
(PRWeb March 12, 2021)
Read the full story at https://www.prweb.com/releases/following_federal_dea_fda_directives_mmj_international_holdings_completing_thc_cbd_marijuana_gel_capsule_manufacturing_for_clinical_trials_in_ms_and_hd/prweb17792331.htm
For more information, please visit
https://www.prweb.com/releases/following[...]in_ms_and_hd/prweb17792331.htm
